Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Aixian Wang"'
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 1, Pp 18-27 (2023)
Objective: In minimal residual disease (MRD) analysis after allogeneic hematopoietic stem cell transplantation (allo-HSCT), abnormal immunophenotyping is commonly considered as evidence of a secondary recurrence or complications, leading to overtreat
Externí odkaz:
https://doaj.org/article/7d09725dfc71435d9a0edcad2eaf0523
Publikováno v:
Journal of Hematopathology. 15:275-278
Publikováno v:
Pediatric Blood & Cancer.
Autor:
Man Chen, Minjing Fu, Wei Zhao, Aixian Wang, Xueying Wu, Meiwei Gong, Junyi Zhen, Guanlan Yue, Hui Wang
Publikováno v:
International Journal of Laboratory Hematology. 45
Publikováno v:
British journal of haematology. 199(3)
Publikováno v:
Open Medicine; Jan2023, Vol. 18 Issue 1, p1-11, 11p, 3 Color Photographs, 3 Graphs
Autor:
Junyi Zhen, Haiyan Gao, Xueying Wu, Tong Wang, Ting Li, Lina Zhang, Hui Wang, Minjing Fu, Qing Du, Meiwei Gong, Xiaoge Zhou, Aixian Wang, Man Chen, Huipeng Sun, Hongxing Liu, Ping Wu
Background: Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is the most prevalent adult leukemia, and its incidence continues to rise year after year. Rapid and precise diagnosis is an essential element in effective case management,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19c408d5d544990a493688baa3eb797b
https://doi.org/10.21203/rs.3.rs-621348/v1
https://doi.org/10.21203/rs.3.rs-621348/v1
Publikováno v:
British Journal of Haematology. 199:305-305
Publikováno v:
International Journal of Laboratory Hematology. 44:21-22
Autor:
Hui, Wang, Hongqin, Liu, Aixian, Wang, Junyi, Zhen, Xueying, Wu, Man, Chen, Meiwei, Gong, Hao, Qu, Shan, Zhou, Xinyong, Tao, Xiaolong, Liao
Publikováno v:
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 36(2)
Objective To prepare a monoclonal antibody (mAb) against human CD33 by immunizing mice with recombinant vector and analyze its characteristics and clinical application. Methods The eukaryotic expression vector pcDNA3.1(+)/CD33 was constructed and use